In NSCLC, the rapamycin mediated inhibition of mTOR signaling can increase the phosphorylation of both Akt and EIF4E through a negative feedback mechanism, while the PI3K inhibitors such as LY294002 can reverse such undesirable effects [33]. Here, EIF4E is linked to non-small cell lung carcinoma.